Essential Reviews in Geriatric Psychiatry
Springer International Publishing (Verlag)
978-3-030-94959-4 (ISBN)
This book critically reviews 75 important published papers that influence the practice of geriatric psychiatry. This book will assist anyone who is interested in the care of older adults with psychiatric disorders. It was written by thought leaders who shape the way geriatric psychiatry is currently practiced in the United States. All the major psychiatric disorders in later life are covered including anxiety disorders, bipolar disorders, depressive disorders, neurocognitive disorders, psychotic disorders, sleep disorders, and substance use disorders. It also reviews important studies on suicides in late life and interventional procedures in geriatric psychiatry like the ECT, and also evaluates the adverse effects of psychotropic medications on older adults with psychiatric disorders.
lt;p> Rajesh R. Tampi, MD, MS, DFAPA, DFAAGP, Cleveland Clinic, Department of Psychiatry & Behavioral Sciences, Cleveland, OH
Dr. Tampi is a Professor of Medicine, Cleveland Clinic Learner College of Medicine of Case Western Reserve University, Chairman, Department of Psychiatry & Behavioral Sciences, Cleveland Clinic Akron General, Akron, Ohio and the Chief, Section for Geriatric Psychiatry, Cleveland Clinic in Cleveland, Ohio. He is also a Professor of Psychiatry at NorthEast Ohio Medical University. Dr. Tampi also maintains his appointment as an Adjunct Professor of Psychiatry at Yale School of Medicine, New Haven, Connecticut. Dr. Tampi is the President of the American Association for Geriatric Psychiatry (AAGP).
Deena J. Tampi, MSN, MBA-HCA, RN, DFAAGP, Diamond Healthcare, Executive Vice President, Richmond, VA
Ms. Tampi is the Executive Vice President of Diamond Healthcare in Richmond, Virginia. Ms. Tampi is on the Board of Directors for the American Association for Geriatric Psychiatry. In addition, she is the Chairperson of the Membership Committee for the American Association for Geriatric Psychiatry.
Juan J. Young, MD, Yale School of Medicine, Geriatric Psychiatry, New Haven, CT
Dr. Young is a current Geriatric Psychiatry Fellow at the Yale School of Medicine, and he also serves in the AAGP Membership Committee.
Meera Balasubramaniam, MD, MPH, NYU Langone Health, Department of Psychiatry, New York, NY
Dr. Meera Balasubramaniam is a Clinical Assistant Professor and the Director of the Geriatric Psychiatry fellowship program at the New York University School of Medicine. She has served on the editorial board of Frontiers in Psychiatry, is an Associate member on the editorial board of the American Journal of Geriatric Psychiatry
Section 1: Adverse effects of medications.- Do atypical antipsychotics cause stroke?.- Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials.- Meta-analysis of the Impact of 9 Medication Classes on Falls in Elderly Persons.- The efficacy and safety of atypical antipsychotics for the treatment of dementia: a meta-analysis of randomized placebo-controlled trials.- Do antipsychotics lead to cognitive impairment in dementia? A meta-analysis of randomised placebo-controlled trials.- A Systematic Review and Meta-Analysis of the Risk of Dementia Associated with Benzodiazepine Use, After Controlling for Protopathic Bias.- Section 2: Anxiety Disorders.- Treatment of panic disorder in older adults: a pilot study comparison of alprazolam, imipramine, and placebo.- Efficacy and tolerability of citalopram in the treatment of late-life anxiety disorders: results froman 8-week randomized, placebo-controlled trial.- Efficacy and tolerability of duloxetine in elderly patients with generalized anxiety disorder: a pooled analysis of four randomized, double-blind, placebo-controlled studies.- Escitalopram for older adults with generalized anxiety disorder: a randomized controlled trial.- Meta-analysis Comparing Different Behavioral Treatments for Late-Life Anxiety.- Cognitive Behavior Therapy for Generalized Anxiety Disorder Among Older Adults in Primary Care: A Randomized Clinical Trial.- Stepped-care prevention of anxiety and depression in late life: a randomized controlled trial.- A randomized controlled study of paroxetine and cognitive-behavioural therapy for late-life panic disorder.- Antidepressant medication augmented with cognitive-behavioral therapy for generalized anxiety disorder in older adults.- A meta-analysis of cognitive functioning in older adults with PTSD.- Anxiety as a Predictor for Cognitive Decline and Dementia: A Systematic Review and Meta-Analysis.- Section 3: Bipolar Disorder.- A Pilot Study of Standardized Treatment in Geriatric Bipolar Disorder.- Differences in clinical features and mental health service use in bipolar disorder across the lifespan.- Effect of antidepressant use on admissions to hospital among elderly bipolar patients.- GERI-BD: A Randomized Double-Blind Controlled Trial of Lithium and Divalproex in the Treatment of Mania in Older Patients With Bipolar Disorder.- History of Bipolar disorder and the risk of dementia: A systematic review and meta-analysis.- Section 4. Delirium.- A Multicomponent Intervention to Prevent Delirium in Hospitalized Older Patients.- Delirium in elderly patients and the risk of post discharge mortality, institutionalization, and dementia: a meta-analysis.- Effectiveness of multicomponent nonpharmacological delirium interventions: a meta-analysis.- Antipsychotic Medication for Prevention and Treatment of Delirium in Hospitalized Adults: A Systematic Review and Meta-Analysis.- Interventions for preventing delirium in older people in institutional long-term care.- Section 5: Depressive Disorders.- Nortriptyline and Interpersonal Psychotherapy as Maintenance Therapies for Recurrent Major Depression. A Randomized Controlled Trial in Patients Older Than 59 Years.- Continuation treatment of delusional depression in older adults.- Reducing suicidal ideation and depressive symptoms in depressed older primary care patients: a randomized controlled trial.- Remission in Depressed Geriatric Primary Care Patients: A Report from the PROSPECT Study.- Executive dysfunction and the course of geriatric depression.- Maintenance Treatment of Major Depression in Old Age.- Placebo-Controlled Study of Relapse Prevention With Risperidone Augmentation in Older Patients with Resistant Depression.- Efficacy of Second-Generation Antidepressants in Late-Life Depression: A Meta-Analysis of the Evidence.- A double-blind randomized controlled trial of olanzapine plus sertraline vs olanzapine plus placebo for psychotic depression: the study of pharmacotherapy of psychotic depression (STOP-PD).- Speed of remission in elderly patients with depression: electroconvulsive therapy v. medication.- A systematic review and meta-analysis of psychotherapy for late-life depression.- A novel strategy for continuation ECT in geriatric depression: phase 2 of the PRIDE Study.- Right Unilateral Ultrabrief Pulse ECT in Geriatric Depression: Phase 1 of the PRIDE Study.- Improvement in Depression is Associated with Improvement in Cognition in Late-Life Psychotic Depression.- Section 6: Electroconvulsive Therapy.- Continuation/Maintenance Treatment with Nortriptyline Versus Combined Nortriptyline and ECT in Late-Life Psychotic Depression: A Two-Year Randomized Study.- Safety and utility of acute electroconvulsive therapy for agitation and aggression in dementia.- Electroconvulsive therapy and risk of dementia in patients with affective disorders: a cohort study.- Electroconvulsive Therapy and Risk of Dementia-A Nationwide Cohort Study in Taiwan.- Section 7: Grief.- Treatment of complicated grief in elderly persons: a randomized clinical trial.- Section 8: Pain Disorders.- Association Between Psychological Interventions and Chronic Pain Outcomes in Older Adults: A Systematic Review and Meta-Analysis.- Section 9: Psychotic Disorders.- A Randomized, Controlled Trial of Cognitive Behavioral Social Skills Training for Middle-Aged and Older Outpatients with Chronic Schizophrenia.- Safety and tolerability of oral paliperidone extended-release tablets in elderly patients with schizophrenia: a double-blind, placebo-controlled study with six-month open-label extension.- Antipsychotic treatment for elderly people with late-onset schizophrenia.- Schizophrenia and risk of dementia: A meta-analysis study.- Antipsychotic treatment of very late-onset schizophrenia-like psychosis (ATLAS): a randomised, controlled, double-blind trial.- Section 10: Neurocognitive Disorders.- Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: a meta-analysis.- Depression and risk for Alzheimer disease: Systematic review, Meta-analysis, and Metaregression analysis.- Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease.- Predictors of progression from mild cognitive impairment to Alzheimer disease.- Efficacy and safety of cognitive enhancers for patients with mild cognitive impairment: a systematic review and meta-analysis.- Personality and risk of Alzheimer's disease: New data and meta-analysis.- Modifiable predictors of dementia in mild cognitive impairment: a systematic review andmeta-analysis.- Pharmacological Management of Lewy Body Dementia: A Systematic Review and Meta-Analysis.- Meta-analysis of modifiable risk factors for Alzheimer's disease.- Memantine for Alzheimer's Disease: An Updated Systematic Review and Meta-analysis.- Update on the Risk of Motor Vehicle Collision or Driving Impairment with Dementia: A Collaborative International Systematic Review and Meta-Analysis.- Pharmacological interventions for apathy in Alzheimer's disease.- Section 11: Sleep Disorders.- Behavioral and Pharmacological Therapies for Late-Life Insomnia: A Randomized Controlled Trial.- Cognitive behavioral therapy vs zopiclone for treatment of chronic primary insomnia in older adults: a randomized controlled trial.- Suvorexant in Elderly Patients with Insomnia: Pooled Analyses of Data from Phase III Randomized Controlled Clinical Trials.- Cognitive behavior therapy for older adults with insomnia and depression: a randomized controlled trial in community mental health services.- Section 12: Suicides.- Medical Illness and the Risk of Suicide in the Elderly.- The Risk of Suicide with Selective Serotonin Reuptake Inhibitors in the Elderly.- Section 13: Substance Use Disorders.- Naltrexone as an Adjunctive Treatment for Older Patients with Alcohol Dependence.- Older adult patients with both Psychiatric and Substance abuse disorders: Prevalence and Health service use.- Five-year alcohol and drug treatment outcomes of older adults versus middle-aged and younger adults in a managed care program.- Treatment of Late-Life Depression Complicated by Alcohol Dependence.- Screening and Brief Intervention for Substance Misuse Among Older Adults: The Florida BRITE Project.
| Erscheinungsdatum | 03.04.2022 |
|---|---|
| Zusatzinfo | XXIV, 442 p. |
| Verlagsort | Cham |
| Sprache | englisch |
| Maße | 155 x 235 mm |
| Gewicht | 988 g |
| Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Psychiatrie / Psychotherapie |
| Schlagworte | Alzheimer's disease • Antipsychotic medication • Chronic schizophrenia • Cognitive Behavioral Therapy • Delirium in Elderly Patients • Electroconvulsive Therapy • Geriatric Bipolar Disorder • Late-life Anxiety • Lewy body dementia • Psychotic Depression |
| ISBN-10 | 3-030-94959-1 / 3030949591 |
| ISBN-13 | 978-3-030-94959-4 / 9783030949594 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich
